Si‑bone (SIBN) edges higher, trading above its 200‑day average, driven by strong demand for its minimally invasive joint tech and a solid R&D pipeline.
Si‑Bone stock jumps 4.48% amid strong earnings and investor confidence, offering a promising entry for value‑seekers in minimally invasive orthopedics.